Full-Time

Business Analyst

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Junior, Mid, Senior

Hyderabad, Telangana, India

Category
Project Management
Business Development
Business & Strategy
Required Skills
Agile
UI/UX Design
Product Management
JIRA
SCRUM
Requirements
  • Master’s degree and 1 to 3 years of Life Science/Biotechnology/Pharmacology/Information Systems experience OR
  • Bachelor’s degree and 3 to 5 years of Life Science/Biotechnology/Pharmacology/Information Systems experience OR
  • Diploma and 7 to 9 years of Life Science/Biotechnology/Pharmacology/Information Systems experience
  • Excellent problem-solving skills and a passion for tackling complex challenges in drug discovery with technology.
  • Experience with Agile software development methodologies (Scrum).
  • Excellent communication skills and the ability to interface with senior leadership with confidence and clarity.
  • Experience in writing requirements for the development of modern web applications.
  • Experience with writing user requirements and acceptance criteria in agile project management systems such as JIRA.
Responsibilities
  • Collaborate with System Architects and Product Managers to manage business analysis activities, ensuring alignment with engineering and product goals.
  • Capture the voice of the customer to define business processes and product needs.
  • Work with Product Managers and customers to define scope and value for new developments.
  • Collaborate with Engineering and Product Management to prioritize release scopes and refine the Product backlog.
  • Ensure non-functional requirements are included and prioritized in the Product and Release Backlogs.
  • Facilitate the breakdown of Epics into Features and Sprint-Sized User Stories and participate in backlog reviews with the development team.
  • Clearly express features in User Stories/requirements so all team members and stakeholders understand how they fit into the product backlog.
  • Ensure Acceptance Criteria and Definition of Done are well-defined.
  • Work closely with UX to align technical requirements, scenarios, and business process maps with User Experience designs.
  • Stay focused on software development to ensure it meets requirements, providing proactive feedback to stakeholders.
  • Develop and execute effective product demonstrations for internal and external stakeholders.
  • Maintain accurate documentation of configurations, processes, and changes.
Desired Qualifications
  • Demonstrated expertise in a scientific domain area and related technology needs.
  • Understanding of scientific software systems strategy, governance, and infrastructure.
  • Experience in managing product features for PI planning and developing product roadmaps and user journeys.
  • Familiarity with low-code, no-code test automation software.
  • Technical thought leadership.
  • Able to communicate technical or complex subject matters in business terms.
  • Jira Align experience.
  • Knowledge of network security protocols and tools (e.g., IPSEC, SSL, IDS/IPS, firewalls).
  • Experience with DevOps, Continuous Integration, and Continuous Delivery methodology.
  • SAFe for Teams certification (preferred).

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The company's goal is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.